The recent approval by the U.S. Securities and Exchange Commission (SEC) of spot Ethereum exchange-traded funds (ETFs) marks a significant…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, reported its financial results for the first quarter ended March…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, has made significant strides of late with the launch of…
Read More »
ELEVAI Labs established two subsidiaries: ELEVAI Biosciences, Inc., and ELEVAI Skincare, Inc. ELEVAI Biosciences will focus on acquiring and developing…
Read More »
The agreement adds two drug candidates to the company’s product pipeline, “EL-22”, a clinical-stage engineered probiotic expressing myostatin, and “EL-32”,…
Read More »
The company’s international distribution agreements have a contracted cumulative minimum purchase requirement of up to $4.9 million over the first…
Read More »
The Asia-Pacific market represents a $13 billion prestige skincare and luxury haircare market opportunity, with the Taiwan deal giving the…
Read More »
With Bitcoin and the overall cryptocurrency market expected to continue rising throughout 2024, investors should consider these blockchain stocks to…
Read More »
ELEVAI Labs (NASDAQ: ELAB) is a California-based medical aesthetic company developing innovative science-driven topical skincare technologies for the medical dispensing…
Read More »